Skip to content
lifestyle.utv.ie
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Sagimet Biosciences Inc.
Sagimet Biosciences to Present Mechanism of Action Data for its FASN Inhibitors at the Society for Investigative Dermatology in Chicago
May 11, 2026
Sagimet Biosciences Announces Pricing of $175.0 Million Underwritten Offering of Series A Common Stock
May 4, 2026
Sagimet Biosciences Provides Strategic and Corporate Updates
May 4, 2026
Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer
May 3, 2026
Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026
Sagimet Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates
March 11, 2026
Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences
February 25, 2026
Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences
February 10, 2026
←
Previous Page
1
2